Risultati di ricerca
5 dic 2020 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020 Dec 5;396 (10265):1807-1816. doi: 10.1016/S0140-6736 (20)32338-2. Epub 2020 Nov 13. Authors.
- Demetris Yannopoulos, Jason Bartos, Ganesh Raveendran, Emily Walser, John Connett, Thomas A Murray, ...
- 2020
27 ago 2023 · The International Liaison Committee on Resuscitation has called for randomised trials of cardiac arrest centres. To our knowledge, ARREST is the first and only randomised trial of delivery to a cardiac arrest centre following resuscitated out-of-hospital cardiac arrest in the community and addresses an important unknown in post ...
13 nov 2020 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial - The Lancet. Articles | Volume 396, ISSUE 10265, P1807-1816, December 05, 2020.
- Demetris Yannopoulos, Jason Bartos, Ganesh Raveendran, Emily Walser, John Connett, Thomas A Murray, ...
- 2020
14 dic 2020 · The ARREST trial Yannopoulos D, Bartos J, Raveendran G, Walser E, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.
25 gen 2023 · The ARREST trial was terminated early because of superiority of the intervention: survival to discharge occurred in 6 of 14 patients (43%) in the group that received extracorporeal CPR as...
3 lug 2021 · The ARREST trial was a phase 2, single-centre, open-label, adaptive, safety and efficacy randomised clinical trial comparing early extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation to standard advanced cardiac life support (ACLS) in adults with out-of-hospital refractory ventricular fibrillation cardiac arrest.
13 nov 2020 · The ARREST trial showed that ECMO was superior to standard ACLS at improving survival to hospital discharge. Description: The goal of the trial was to evaluate extracorporeal membrane oxygenation (ECMO) initiated in the catheterization laboratory compared with standard advanced cardiac life support (ACLS) among patients with out-of ...
